Chugai Pharmaceutical Co., Ltd. (CHGCF) Stock Competitors & Peer Comparison
See (CHGCF) competitors and their performances in Stock Market.
Peer Comparison Table: Drug Manufacturers - General Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| CHGCF | $45.01 | -4.09% | 75.5B | 27.80 | $1.65 | +3.93% |
| BMYMP | $400.00 | -57.46% | 814.6B | 1777.78 | $0.23 | +4.43% |
| RHHVF | $411.25 | -2.70% | 327.4B | 20.21 | $20.35 | +3.02% |
| RHHBF | $414.00 | -0.54% | 325.6B | 20.17 | $20.28 | +3.03% |
| RHHBY | $50.43 | -0.23% | 322B | 19.84 | $2.52 | +3.09% |
| AZNCF | $189.90 | -1.35% | 294.4B | 31.49 | $6.03 | +1.41% |
| NVSEF | $148.80 | +3.23% | 283.9B | 21.32 | $6.98 | +3.19% |
| SNYNF | $86.67 | -1.19% | 104.2B | 18.84 | $4.60 | +5.59% |
| GLAXF | $25.12 | +1.86% | 98.9B | 12.98 | $1.90 | +3.64% |
| CHGCY | $23.37 | -0.68% | 75.2B | 27.85 | $0.82 | +3.61% |
Stock Comparison
CHGCF vs BMYMP Comparison June 2026
CHGCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHGCF stands at 75.5B. In comparison, BMYMP has a market cap of 814.6B. Regarding current trading prices, CHGCF is priced at $45.01, while BMYMP trades at $400.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHGCF currently has a P/E ratio of 27.80, whereas BMYMP's P/E ratio is 1777.78. In terms of profitability, CHGCF's ROE is +0.23%, compared to BMYMP's ROE of +0.39%. Regarding short-term risk, CHGCF is less volatile compared to BMYMP. This indicates potentially lower risk in terms of short-term price fluctuations for CHGCF.Check BMYMP's competition here
CHGCF vs RHHVF Comparison June 2026
CHGCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHGCF stands at 75.5B. In comparison, RHHVF has a market cap of 327.4B. Regarding current trading prices, CHGCF is priced at $45.01, while RHHVF trades at $411.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHGCF currently has a P/E ratio of 27.80, whereas RHHVF's P/E ratio is 20.21. In terms of profitability, CHGCF's ROE is +0.23%, compared to RHHVF's ROE of +0.41%. Regarding short-term risk, CHGCF is less volatile compared to RHHVF. This indicates potentially lower risk in terms of short-term price fluctuations for CHGCF.Check RHHVF's competition here
CHGCF vs RHHBF Comparison June 2026
CHGCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHGCF stands at 75.5B. In comparison, RHHBF has a market cap of 325.6B. Regarding current trading prices, CHGCF is priced at $45.01, while RHHBF trades at $414.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHGCF currently has a P/E ratio of 27.80, whereas RHHBF's P/E ratio is 20.17. In terms of profitability, CHGCF's ROE is +0.23%, compared to RHHBF's ROE of +0.29%. Regarding short-term risk, CHGCF is more volatile compared to RHHBF. This indicates potentially higher risk in terms of short-term price fluctuations for CHGCF.Check RHHBF's competition here
CHGCF vs RHHBY Comparison June 2026
CHGCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHGCF stands at 75.5B. In comparison, RHHBY has a market cap of 322B. Regarding current trading prices, CHGCF is priced at $45.01, while RHHBY trades at $50.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHGCF currently has a P/E ratio of 27.80, whereas RHHBY's P/E ratio is 19.84. In terms of profitability, CHGCF's ROE is +0.23%, compared to RHHBY's ROE of +0.29%. Regarding short-term risk, CHGCF is more volatile compared to RHHBY. This indicates potentially higher risk in terms of short-term price fluctuations for CHGCF.Check RHHBY's competition here
CHGCF vs AZNCF Comparison June 2026
CHGCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHGCF stands at 75.5B. In comparison, AZNCF has a market cap of 294.4B. Regarding current trading prices, CHGCF is priced at $45.01, while AZNCF trades at $189.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHGCF currently has a P/E ratio of 27.80, whereas AZNCF's P/E ratio is 31.49. In terms of profitability, CHGCF's ROE is +0.23%, compared to AZNCF's ROE of +0.23%. Regarding short-term risk, CHGCF is less volatile compared to AZNCF. This indicates potentially lower risk in terms of short-term price fluctuations for CHGCF.Check AZNCF's competition here
CHGCF vs NVSEF Comparison June 2026
CHGCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHGCF stands at 75.5B. In comparison, NVSEF has a market cap of 283.9B. Regarding current trading prices, CHGCF is priced at $45.01, while NVSEF trades at $148.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHGCF currently has a P/E ratio of 27.80, whereas NVSEF's P/E ratio is 21.32. In terms of profitability, CHGCF's ROE is +0.23%, compared to NVSEF's ROE of +0.32%. Regarding short-term risk, CHGCF is more volatile compared to NVSEF. This indicates potentially higher risk in terms of short-term price fluctuations for CHGCF.Check NVSEF's competition here
CHGCF vs SNYNF Comparison June 2026
CHGCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHGCF stands at 75.5B. In comparison, SNYNF has a market cap of 104.2B. Regarding current trading prices, CHGCF is priced at $45.01, while SNYNF trades at $86.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHGCF currently has a P/E ratio of 27.80, whereas SNYNF's P/E ratio is 18.84. In terms of profitability, CHGCF's ROE is +0.23%, compared to SNYNF's ROE of +0.14%. Regarding short-term risk, CHGCF is more volatile compared to SNYNF. This indicates potentially higher risk in terms of short-term price fluctuations for CHGCF.Check SNYNF's competition here
CHGCF vs GLAXF Comparison June 2026
CHGCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHGCF stands at 75.5B. In comparison, GLAXF has a market cap of 98.9B. Regarding current trading prices, CHGCF is priced at $45.01, while GLAXF trades at $25.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHGCF currently has a P/E ratio of 27.80, whereas GLAXF's P/E ratio is 12.98. In terms of profitability, CHGCF's ROE is +0.23%, compared to GLAXF's ROE of +0.33%. Regarding short-term risk, CHGCF is more volatile compared to GLAXF. This indicates potentially higher risk in terms of short-term price fluctuations for CHGCF.Check GLAXF's competition here
CHGCF vs CHGCY Comparison June 2026
CHGCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHGCF stands at 75.5B. In comparison, CHGCY has a market cap of 75.2B. Regarding current trading prices, CHGCF is priced at $45.01, while CHGCY trades at $23.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHGCF currently has a P/E ratio of 27.80, whereas CHGCY's P/E ratio is 27.85. In terms of profitability, CHGCF's ROE is +0.23%, compared to CHGCY's ROE of +0.24%. Regarding short-term risk, CHGCF is less volatile compared to CHGCY. This indicates potentially lower risk in terms of short-term price fluctuations for CHGCF.Check CHGCY's competition here
CHGCF vs BAYRY Comparison June 2026
CHGCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHGCF stands at 75.5B. In comparison, BAYRY has a market cap of 40.2B. Regarding current trading prices, CHGCF is priced at $45.01, while BAYRY trades at $10.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHGCF currently has a P/E ratio of 27.80, whereas BAYRY's P/E ratio is -15.97. In terms of profitability, CHGCF's ROE is +0.23%, compared to BAYRY's ROE of -0.07%. Regarding short-term risk, CHGCF is more volatile compared to BAYRY. This indicates potentially higher risk in terms of short-term price fluctuations for CHGCF.Check BAYRY's competition here
CHGCF vs OTSKF Comparison June 2026
CHGCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHGCF stands at 75.5B. In comparison, OTSKF has a market cap of 33.7B. Regarding current trading prices, CHGCF is priced at $45.01, while OTSKF trades at $64.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHGCF currently has a P/E ratio of 27.80, whereas OTSKF's P/E ratio is 14.95. In terms of profitability, CHGCF's ROE is +0.23%, compared to OTSKF's ROE of +0.13%. Regarding short-term risk, CHGCF is more volatile compared to OTSKF. This indicates potentially higher risk in terms of short-term price fluctuations for CHGCF.Check OTSKF's competition here
CHGCF vs OTSKY Comparison June 2026
CHGCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHGCF stands at 75.5B. In comparison, OTSKY has a market cap of 33.6B. Regarding current trading prices, CHGCF is priced at $45.01, while OTSKY trades at $31.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHGCF currently has a P/E ratio of 27.80, whereas OTSKY's P/E ratio is 14.91. In terms of profitability, CHGCF's ROE is +0.23%, compared to OTSKY's ROE of +0.13%. Regarding short-term risk, CHGCF is less volatile compared to OTSKY. This indicates potentially lower risk in terms of short-term price fluctuations for CHGCF.Check OTSKY's competition here
CHGCF vs DSNKY Comparison June 2026
CHGCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHGCF stands at 75.5B. In comparison, DSNKY has a market cap of 29B. Regarding current trading prices, CHGCF is priced at $45.01, while DSNKY trades at $15.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHGCF currently has a P/E ratio of 27.80, whereas DSNKY's P/E ratio is 18.12. In terms of profitability, CHGCF's ROE is +0.23%, compared to DSNKY's ROE of +0.16%. Regarding short-term risk, CHGCF is more volatile compared to DSNKY. This indicates potentially higher risk in terms of short-term price fluctuations for CHGCF.Check DSNKY's competition here
CHGCF vs DSKYF Comparison June 2026
CHGCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHGCF stands at 75.5B. In comparison, DSKYF has a market cap of 27B. Regarding current trading prices, CHGCF is priced at $45.01, while DSKYF trades at $14.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHGCF currently has a P/E ratio of 27.80, whereas DSKYF's P/E ratio is 16.89. In terms of profitability, CHGCF's ROE is +0.23%, compared to DSKYF's ROE of +0.16%. Regarding short-term risk, CHGCF and DSKYF have similar daily volatility (2.02).Check DSKYF's competition here
CHGCF vs ALPMY Comparison June 2026
CHGCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHGCF stands at 75.5B. In comparison, ALPMY has a market cap of 23.7B. Regarding current trading prices, CHGCF is priced at $45.01, while ALPMY trades at $13.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHGCF currently has a P/E ratio of 27.80, whereas ALPMY's P/E ratio is 13.12. In terms of profitability, CHGCF's ROE is +0.23%, compared to ALPMY's ROE of +0.18%. Regarding short-term risk, CHGCF is more volatile compared to ALPMY. This indicates potentially higher risk in terms of short-term price fluctuations for CHGCF.Check ALPMY's competition here
CHGCF vs ALPMF Comparison June 2026
CHGCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHGCF stands at 75.5B. In comparison, ALPMF has a market cap of 23.7B. Regarding current trading prices, CHGCF is priced at $45.01, while ALPMF trades at $13.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHGCF currently has a P/E ratio of 27.80, whereas ALPMF's P/E ratio is 13.12. In terms of profitability, CHGCF's ROE is +0.23%, compared to ALPMF's ROE of +0.17%. Regarding short-term risk, CHGCF is more volatile compared to ALPMF. This indicates potentially higher risk in terms of short-term price fluctuations for CHGCF.Check ALPMF's competition here
CHGCF vs ORINY Comparison June 2026
CHGCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHGCF stands at 75.5B. In comparison, ORINY has a market cap of 22.9B. Regarding current trading prices, CHGCF is priced at $45.01, while ORINY trades at $40.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHGCF currently has a P/E ratio of 27.80, whereas ORINY's P/E ratio is 18.64. In terms of profitability, CHGCF's ROE is +0.23%, compared to ORINY's ROE of +0.49%. Regarding short-term risk, CHGCF is more volatile compared to ORINY. This indicates potentially higher risk in terms of short-term price fluctuations for CHGCF.Check ORINY's competition here
CHGCF vs GIKLY Comparison June 2026
CHGCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHGCF stands at 75.5B. In comparison, GIKLY has a market cap of 14.2B. Regarding current trading prices, CHGCF is priced at $45.01, while GIKLY trades at $5.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHGCF currently has a P/E ratio of 27.80, whereas GIKLY's P/E ratio is 15.40. In terms of profitability, CHGCF's ROE is +0.23%, compared to GIKLY's ROE of +0.08%. Regarding short-term risk, CHGCF is more volatile compared to GIKLY. This indicates potentially higher risk in terms of short-term price fluctuations for CHGCF.Check GIKLY's competition here
CHGCF vs RCDTF Comparison June 2026
CHGCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHGCF stands at 75.5B. In comparison, RCDTF has a market cap of 12.2B. Regarding current trading prices, CHGCF is priced at $45.01, while RCDTF trades at $60.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHGCF currently has a P/E ratio of 27.80, whereas RCDTF's P/E ratio is 22.90. In terms of profitability, CHGCF's ROE is +0.23%, compared to RCDTF's ROE of +0.24%. Regarding short-term risk, CHGCF is more volatile compared to RCDTF. This indicates potentially higher risk in terms of short-term price fluctuations for CHGCF.Check RCDTF's competition here
CHGCF vs CHJTF Comparison June 2026
CHGCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHGCF stands at 75.5B. In comparison, CHJTF has a market cap of 12B. Regarding current trading prices, CHGCF is priced at $45.01, while CHJTF trades at $1.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHGCF currently has a P/E ratio of 27.80, whereas CHJTF's P/E ratio is 21.00. In terms of profitability, CHGCF's ROE is +0.23%, compared to CHJTF's ROE of +0.05%. Regarding short-term risk, CHGCF is more volatile compared to CHJTF. This indicates potentially higher risk in terms of short-term price fluctuations for CHGCF.Check CHJTF's competition here
CHGCF vs ORINF Comparison June 2026
CHGCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHGCF stands at 75.5B. In comparison, ORINF has a market cap of 11.7B. Regarding current trading prices, CHGCF is priced at $45.01, while ORINF trades at $82.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHGCF currently has a P/E ratio of 27.80, whereas ORINF's P/E ratio is 18.98. In terms of profitability, CHGCF's ROE is +0.23%, compared to ORINF's ROE of +0.49%. Regarding short-term risk, CHGCF is more volatile compared to ORINF. This indicates potentially higher risk in terms of short-term price fluctuations for CHGCF.Check ORINF's competition here
CHGCF vs CSPCY Comparison June 2026
CHGCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHGCF stands at 75.5B. In comparison, CSPCY has a market cap of 10.2B. Regarding current trading prices, CHGCF is priced at $45.01, while CSPCY trades at $3.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHGCF currently has a P/E ratio of 27.80, whereas CSPCY's P/E ratio is 17.65. In terms of profitability, CHGCF's ROE is +0.23%, compared to CSPCY's ROE of +0.05%. Regarding short-term risk, CHGCF is less volatile compared to CSPCY. This indicates potentially lower risk in terms of short-term price fluctuations for CHGCF.Check CSPCY's competition here
CHGCF vs GIFOF Comparison June 2026
CHGCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHGCF stands at 75.5B. In comparison, GIFOF has a market cap of 8.7B. Regarding current trading prices, CHGCF is priced at $45.01, while GIFOF trades at $8.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHGCF currently has a P/E ratio of 27.80, whereas GIFOF's P/E ratio is 12.46. In terms of profitability, CHGCF's ROE is +0.23%, compared to GIFOF's ROE of +0.08%. Regarding short-term risk, CHGCF is more volatile compared to GIFOF. This indicates potentially higher risk in terms of short-term price fluctuations for CHGCF.Check GIFOF's competition here
CHGCF vs GIFLF Comparison June 2026
CHGCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHGCF stands at 75.5B. In comparison, GIFLF has a market cap of 7.6B. Regarding current trading prices, CHGCF is priced at $45.01, while GIFLF trades at $10.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHGCF currently has a P/E ratio of 27.80, whereas GIFLF's P/E ratio is 15.66. In terms of profitability, CHGCF's ROE is +0.23%, compared to GIFLF's ROE of +0.08%. Regarding short-term risk, CHGCF is more volatile compared to GIFLF. This indicates potentially higher risk in terms of short-term price fluctuations for CHGCF.Check GIFLF's competition here
CHGCF vs OPHLF Comparison June 2026
CHGCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHGCF stands at 75.5B. In comparison, OPHLF has a market cap of 6.8B. Regarding current trading prices, CHGCF is priced at $45.01, while OPHLF trades at $14.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHGCF currently has a P/E ratio of 27.80, whereas OPHLF's P/E ratio is 15.65. In terms of profitability, CHGCF's ROE is +0.23%, compared to OPHLF's ROE of +0.09%. Regarding short-term risk, CHGCF is more volatile compared to OPHLF. This indicates potentially higher risk in terms of short-term price fluctuations for CHGCF.Check OPHLF's competition here
CHGCF vs KYKOF Comparison June 2026
CHGCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHGCF stands at 75.5B. In comparison, KYKOF has a market cap of 6.7B. Regarding current trading prices, CHGCF is priced at $45.01, while KYKOF trades at $12.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHGCF currently has a P/E ratio of 27.80, whereas KYKOF's P/E ratio is 16.05. In terms of profitability, CHGCF's ROE is +0.23%, compared to KYKOF's ROE of +0.08%. Regarding short-term risk, CHGCF is more volatile compared to KYKOF. This indicates potentially higher risk in terms of short-term price fluctuations for CHGCF.Check KYKOF's competition here
CHGCF vs OPHLY Comparison June 2026
CHGCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHGCF stands at 75.5B. In comparison, OPHLY has a market cap of 6.4B. Regarding current trading prices, CHGCF is priced at $45.01, while OPHLY trades at $4.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHGCF currently has a P/E ratio of 27.80, whereas OPHLY's P/E ratio is 14.71. In terms of profitability, CHGCF's ROE is +0.23%, compared to OPHLY's ROE of +0.09%. Regarding short-term risk, CHGCF is more volatile compared to OPHLY. This indicates potentially higher risk in terms of short-term price fluctuations for CHGCF.Check OPHLY's competition here
CHGCF vs DPHAY Comparison June 2026
CHGCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHGCF stands at 75.5B. In comparison, DPHAY has a market cap of 5.6B. Regarding current trading prices, CHGCF is priced at $45.01, while DPHAY trades at $98.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHGCF currently has a P/E ratio of 27.80, whereas DPHAY's P/E ratio is -155.56. In terms of profitability, CHGCF's ROE is +0.23%, compared to DPHAY's ROE of -0.04%. Regarding short-term risk, CHGCF is more volatile compared to DPHAY. This indicates potentially higher risk in terms of short-term price fluctuations for CHGCF.Check DPHAY's competition here
CHGCF vs SNPHY Comparison June 2026
CHGCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHGCF stands at 75.5B. In comparison, SNPHY has a market cap of 3.9B. Regarding current trading prices, CHGCF is priced at $45.01, while SNPHY trades at $12.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHGCF currently has a P/E ratio of 27.80, whereas SNPHY's P/E ratio is 17.23. In terms of profitability, CHGCF's ROE is +0.23%, compared to SNPHY's ROE of +0.13%. Regarding short-term risk, CHGCF is less volatile compared to SNPHY. This indicates potentially lower risk in terms of short-term price fluctuations for CHGCF.Check SNPHY's competition here
CHGCF vs VRBCF Comparison June 2026
CHGCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHGCF stands at 75.5B. In comparison, VRBCF has a market cap of 3.6B. Regarding current trading prices, CHGCF is priced at $45.01, while VRBCF trades at $431.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHGCF currently has a P/E ratio of 27.80, whereas VRBCF's P/E ratio is 20.83. In terms of profitability, CHGCF's ROE is +0.23%, compared to VRBCF's ROE of +0.14%. Regarding short-term risk, CHGCF is more volatile compared to VRBCF. This indicates potentially higher risk in terms of short-term price fluctuations for CHGCF.Check VRBCF's competition here
CHGCF vs SNPHF Comparison June 2026
CHGCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHGCF stands at 75.5B. In comparison, SNPHF has a market cap of 3.5B. Regarding current trading prices, CHGCF is priced at $45.01, while SNPHF trades at $10.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHGCF currently has a P/E ratio of 27.80, whereas SNPHF's P/E ratio is 15.48. In terms of profitability, CHGCF's ROE is +0.23%, compared to SNPHF's ROE of +0.17%. Regarding short-term risk, CHGCF is more volatile compared to SNPHF. This indicates potentially higher risk in terms of short-term price fluctuations for CHGCF.Check SNPHF's competition here
CHGCF vs HAWPY Comparison June 2026
CHGCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHGCF stands at 75.5B. In comparison, HAWPY has a market cap of 3B. Regarding current trading prices, CHGCF is priced at $45.01, while HAWPY trades at $54.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHGCF currently has a P/E ratio of 27.80, whereas HAWPY's P/E ratio is 14.52. In terms of profitability, CHGCF's ROE is +0.23%, compared to HAWPY's ROE of +0.06%. Regarding short-term risk, CHGCF is more volatile compared to HAWPY. This indicates potentially higher risk in terms of short-term price fluctuations for CHGCF.Check HAWPY's competition here
CHGCF vs HAWPF Comparison June 2026
CHGCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHGCF stands at 75.5B. In comparison, HAWPF has a market cap of 2.7B. Regarding current trading prices, CHGCF is priced at $45.01, while HAWPF trades at $12.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHGCF currently has a P/E ratio of 27.80, whereas HAWPF's P/E ratio is 12.90. In terms of profitability, CHGCF's ROE is +0.23%, compared to HAWPF's ROE of +0.06%. Regarding short-term risk, CHGCF is more volatile compared to HAWPF. This indicates potentially higher risk in terms of short-term price fluctuations for CHGCF.Check HAWPF's competition here
CHGCF vs PTKFF Comparison June 2026
CHGCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHGCF stands at 75.5B. In comparison, PTKFF has a market cap of 1.9B. Regarding current trading prices, CHGCF is priced at $45.01, while PTKFF trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHGCF currently has a P/E ratio of 27.80, whereas PTKFF's P/E ratio is N/A. In terms of profitability, CHGCF's ROE is +0.23%, compared to PTKFF's ROE of +0.16%. Regarding short-term risk, CHGCF is more volatile compared to PTKFF. This indicates potentially higher risk in terms of short-term price fluctuations for CHGCF.Check PTKFF's competition here
CHGCF vs LYPHF Comparison June 2026
CHGCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHGCF stands at 75.5B. In comparison, LYPHF has a market cap of 1.6B. Regarding current trading prices, CHGCF is priced at $45.01, while LYPHF trades at $0.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHGCF currently has a P/E ratio of 27.80, whereas LYPHF's P/E ratio is 19.75. In terms of profitability, CHGCF's ROE is +0.23%, compared to LYPHF's ROE of +0.04%. Regarding short-term risk, CHGCF is less volatile compared to LYPHF. This indicates potentially lower risk in terms of short-term price fluctuations for CHGCF.Check LYPHF's competition here
CHGCF vs TGRNF Comparison June 2026
CHGCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHGCF stands at 75.5B. In comparison, TGRNF has a market cap of 657.6M. Regarding current trading prices, CHGCF is priced at $45.01, while TGRNF trades at $0.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHGCF currently has a P/E ratio of 27.80, whereas TGRNF's P/E ratio is 10.27. In terms of profitability, CHGCF's ROE is +0.23%, compared to TGRNF's ROE of +0.05%. Regarding short-term risk, CHGCF is more volatile compared to TGRNF. This indicates potentially higher risk in terms of short-term price fluctuations for CHGCF.Check TGRNF's competition here
CHGCF vs JCRRF Comparison June 2026
CHGCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHGCF stands at 75.5B. In comparison, JCRRF has a market cap of 383.7M. Regarding current trading prices, CHGCF is priced at $45.01, while JCRRF trades at $3.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHGCF currently has a P/E ratio of 27.80, whereas JCRRF's P/E ratio is 28.59. In terms of profitability, CHGCF's ROE is +0.23%, compared to JCRRF's ROE of +0.06%. Regarding short-term risk, CHGCF is more volatile compared to JCRRF. This indicates potentially higher risk in terms of short-term price fluctuations for CHGCF.Check JCRRF's competition here
CHGCF vs MAYNF Comparison June 2026
CHGCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHGCF stands at 75.5B. In comparison, MAYNF has a market cap of 125.9M. Regarding current trading prices, CHGCF is priced at $45.01, while MAYNF trades at $1.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHGCF currently has a P/E ratio of 27.80, whereas MAYNF's P/E ratio is -2.09. In terms of profitability, CHGCF's ROE is +0.23%, compared to MAYNF's ROE of -0.23%. Regarding short-term risk, CHGCF is more volatile compared to MAYNF. This indicates potentially higher risk in terms of short-term price fluctuations for CHGCF.Check MAYNF's competition here
CHGCF vs PTKFY Comparison June 2026
CHGCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHGCF stands at 75.5B. In comparison, PTKFY has a market cap of 11.6M. Regarding current trading prices, CHGCF is priced at $45.01, while PTKFY trades at $10.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHGCF currently has a P/E ratio of 27.80, whereas PTKFY's P/E ratio is 11.65. In terms of profitability, CHGCF's ROE is +0.23%, compared to PTKFY's ROE of +0.16%. Regarding short-term risk, CHGCF is more volatile compared to PTKFY. This indicates potentially higher risk in terms of short-term price fluctuations for CHGCF.Check PTKFY's competition here
CHGCF vs PSYGF Comparison June 2026
CHGCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHGCF stands at 75.5B. In comparison, PSYGF has a market cap of 2.2M. Regarding current trading prices, CHGCF is priced at $45.01, while PSYGF trades at $0.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHGCF currently has a P/E ratio of 27.80, whereas PSYGF's P/E ratio is -0.19. In terms of profitability, CHGCF's ROE is +0.23%, compared to PSYGF's ROE of -14.36%. Regarding short-term risk, CHGCF is less volatile compared to PSYGF. This indicates potentially lower risk in terms of short-term price fluctuations for CHGCF.Check PSYGF's competition here
CHGCF vs CRXTQ Comparison June 2026
CHGCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHGCF stands at 75.5B. In comparison, CRXTQ has a market cap of 72.8K. Regarding current trading prices, CHGCF is priced at $45.01, while CRXTQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHGCF currently has a P/E ratio of 27.80, whereas CRXTQ's P/E ratio is -0.00. In terms of profitability, CHGCF's ROE is +0.23%, compared to CRXTQ's ROE of +0.33%. Regarding short-term risk, CHGCF is more volatile compared to CRXTQ. This indicates potentially higher risk in terms of short-term price fluctuations for CHGCF.Check CRXTQ's competition here